Retrospective cohort study for assessment of association between imaging changes and outcome after treatment of regorafenib(KSCC1603)

Trial Profile

Retrospective cohort study for assessment of association between imaging changes and outcome after treatment of regorafenib(KSCC1603)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Jul 2017

At a glance

  • Drugs Regorafenib (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jul 2017 Status changed from recruiting to active, no longer recruiting.
    • 13 Jan 2017 Status changed from not yet recruiting to recruiting.
    • 27 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top